Dr. Leah Helen Ansell, MD

Dr. Ansell practices at Ruth Kaplan Treiber, MD & Eric S. Treiber, MD in Rye, New York.

Dr. Ansell's NPI, 1114260429, was assigned on April 4, 2013. Dr. Ansell graduated from Feinberg School of Medicine in 2013. Dr. Ansell holds New York license 288450-1.

Dr. Ansell's primary practice is Ruth Kaplan Treiber, MD & Eric S. Treiber, MD, at 175 Purchase St, Rye, NY 10580 in Westchester County. The practice phone is (914) 967-2153.

Dr. Ansell's primary practice is Ruth Kaplan Treiber, MD & Eric S. Treiber, MD in Rye, New York. The medical group on file is Treiber Derm. Dmand AI also links Dr. Ansell to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ansell practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Ansell's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ansell is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Ansell's licenses on file in 2 states: New York and Illinois.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection, hives and itchy rashes among the conditions Dr. Ansell treats.

CMS data shows 1,972 Medicare services from Dr. Ansell across 15 procedure codes in 2024, for 506 Medicare patients. Medicare paid $118,727 for them. Every service was in an office.

CMS counts 506 Medicare patients who saw Dr. Ansell in 2024. The largest group is 65 to 74, with 251 patients. 75% of them have high cholesterol, and 51% have high blood pressure. Their average risk score is 0.81, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ansell's median patient age at 49, with 66% women.

In 2024, Dr. Ansell wrote 560 Medicare Part D claims for 249 patients. 85% of them were for generic drugs. CMS names the drug for 484 of them, across 14 drugs with 11 or more claims each, at $149,298 in total drug cost. In 2023, CMS named 428 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ansell for performance year 2024, reported as part of a group. Dr. Ansell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 388 procedures of skin biopsy by Dr. Ansell, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Ansell, published from 2015 to 2016. Dr. Ansell's most frequent co-authors are Megan L. Curran, MD, Margaret Lynn Dowd, MD and Sameera Husain, MD.

CMS Open Payments shows 318 general payments to Dr. Ansell from 34 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,057.

Dmand AI lists 2 awards for Dr. Ansell, most recently Chief Resident, Dermatology in 2017.

Dr. Ansell graduated from Feinberg School of Medicine in 2013.

Dr. Ansell is in network with 10 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.